期刊文献+

雷帕霉素对TGF-β1诱导的Treg细胞的体外影响 被引量:1

Effect of rapamycin on regulator T cells induced by TGF-β1 in vitro
下载PDF
导出
摘要 目的体外观察雷帕霉素(Rapa)对转化生长因子-β1(TGF-β1)诱导的CD4+CD25+Treg细胞(i Treg)扩增的有效性及其相关性。方法以抗原提呈细胞(APC)、植物血凝素(PHA,10μg.L-1)、TGF-β1(7.5 ng.L-1)联合刺激诱导CD4+CD25-T细胞转化为CD4+CD25+Treg细胞,培养第5日添加不同浓度Rapa刺激培养3d作为实验组,设阴性对照组(不加Rapa)和空白对照组(RPMI 1640培养基),FCM检测各组中CD4+CD25+T细胞比例变化情况;MTT法测定各组诱导细胞的抑制功能。结果①阴性对照组CD4+CD25+T细胞比例较空白对照组增高(P<0.01),而实验组CD4+CD25+T细胞比例显著升高,Rapa(100 ng.mL-1)增殖效应显著(P<0.01),CD4+CD25+T细胞增殖比例达到42.6%;②实验组i Treg细胞能够明显抑制同型CD4+CD25-T细胞的增殖(P<0.01)且不同浓度Rapa之间存在差异,100 ng.mL-1Rapa抑制效应最明显(P<0.01)。结论在体外条件下,Rapa可以促进TGF-β1诱导分化的Treg细胞增殖,且具有免疫抑制功能,这为体外回输Treg细胞治疗疾病开辟了新途径。 Objective To investigate the effect of rapamycin on TGF-β1-induced Treg cells(iTreg) in vitro.Methods After CD4^+CD25^-T cells were stimulated with antigen-presenting cells(APC),PHA and TGF-β1 for 5 d,different levels of rapamycin were added into the cluture system(to establish an experimental group and a control group without rapamycin,while CD4^+CD25^-T cells co-cultured with RPMI 1640 were taken as a placebo group.After 3 days the stimulation percentage of CD4^+CD25^+T cells was detected by FCM and the inhibitory effect of proliferated iTreg was tested.Results ① The percentage of CD4^+CD25^+T cells in the negative control group was higher than that in the placebo control group(P〈0.01).The percentage of CD4^+CD25^+T cells in the experimental group markedly exceeded that of the negative control group(P〈0.01).After a 3-day culture,100 ng·mL-1 rapamycin was the optimum level that led to the most obvious expansion of iTreg cells(42.6%) in vitro.② Proliferation of CD4^+CD25^-T cells was suppressed by iTreg cultured with different levels of rapamycin(P〈0.01),and 100 ng·mL^-1 rapamycin had the most significant inhibitory effect.Conclusion Rapamycin can expand TGF-β1 induced Treg cells and iTregs can inhibit the proliferation of CD4^+CD25^-T cells,which is expected to open up a new way for Treg cells refusion in vitro.
出处 《中南药学》 CAS 2010年第6期437-441,共5页 Central South Pharmacy
关键词 雷帕霉素 转化生长因子-Β1 CD4+CD25-调节性T细胞 rapamycin TGF-β1 CD4^+CD25^+regulator T cell
  • 引文网络
  • 相关文献

参考文献13

  • 1Vang KB,Yang J,Mahmud SA,et al.IL-2,-7 and IL-15,but not thymic stromal lymphopoeitin,redundantly govern CD4^+ Foxp3^+ regulatory T cell development[J].J Immunol,2008,181(5):3285-3290.
  • 2Suntharalingam G,Perry MR,Ward S,et al.Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412[J].N Engl J Med,2006,355(10):1018-1028.
  • 3Karagiannis TC,El-Osta A.Clinical potential of histone deacetylase inhibitors as stand alone therapeutics and in combination with other chemotherapeutics or radiotherapy for cancer[J].Epigenetics,2006,1(3):121-126.
  • 4Battaglia M,Stabilini A,Migliavacca B,et al.Rapamycin promotes expansion of functional CD4^+CD25^+ FOXP3^+ regulatory T cells of both healthy subjects and type 1 diabetic patients[J].J Immunol,2006,177(12):8338-8347.
  • 5D'Alessio FR,Tsushima K,Aggarwal NR,et al.CD4^+ CD25^+ FOXP3^+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury[J].J Clin Invest,2009,119(10):2898-2913.
  • 6Abe Y,Urakami H,Ostanin D,et al.Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts[J].PLoS One,2009,4(11):e7840.
  • 7Long KZ,Rosado JL,Santos JI,et al.Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections[J].Infect Immun,2009,78(3):1221-1228.
  • 8Bakke AC,Purtzer MZ,Wildin RS.Prospective immunological profiling in a case of immune dysregulation,polyendocrinopathy,enteropathy,X-linked syndrome (IPEX)[J].Clin Exp Immunol,2004,137(2):373-378.
  • 9Corthay A.How do Regulatory T Cells Work?[J].Scand J Immunol,2009,70(4):326-36.
  • 10Laura Strauss,Malgorzata Czystowska,et al.Whiteside.Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin[J].PLoS ONE,2009,4(6):e5994.

二级参考文献23

  • 1骆群,吕明,于鸣,黎燕.抗CD28抗体协同刺激增强抗CD3抗体体外激活T淋巴细胞并降低TGF-β的表达[J].中国实验血液学杂志,2006,14(3):547-551. 被引量:7
  • 2Flechner SM, Goldfarb D, Modlin C, et al. Kidney transplantion without calcineurin inhibitor drugs: a prospective randomized trail of sirohmus versus cyclosperine [ J]. Transplant, 2002, 74 (8) : 1070-1076.
  • 3Strauss L, Whiteside TL, Knights A, et al. Selective survival of naturally occurring human CD4^+ CD25^+ FoxP3^+ regulatory T cells cultured with rapamycin [ J ]. J Immunol, 2007, 178(1) :320-329.
  • 4Battaglia M, Stabilini A, Migliavacca B, et al. Rapamycin promotes expansion of functional CD4^+ CD25^+ FOXP3^+ regulatory T cells of both healthy subjects and type 1 diabetic patients [ J]. J Immunol, 2006, 177 (12) :8338-8347.
  • 5Oliveira V, Agua-Doce A, Duarte J, et al. Regulatory T cell maintenance of dominant tolerance: induction of tissue self-defense [J]. Transpl Immunol, 2006, 17(1) :7-10.
  • 6Kingsley CI, Karim M, Bushell AR, et al. CD25^+ CD4^+ regulatory T cells prevent graft rejection: CTLA-4 and IL-10 dependent immunoregulation of alloresponses [ J]. J Immunol, 2002, 168(3):1080-1086.
  • 7Cobbold S, Waldmann H. Infectious tolerance [J]. Curr Opin Immunol, 1998, 10(5) :518-524.
  • 8Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts [ J]. J Exp Med, 2002, 195 (12) : 1641-1646.
  • 9Zheng XX, Sanchez-Fueyo A, Domenig C, et al. The balance of deletion and regulation in allograft tolerance [ J ]. Immunol Rev, 2003, 196(1) :75-84.
  • 10Sanchez-Fueyo A, Weber M, Domenig C, et al. Tracking the immunoregulatory mechanisms active during allograft tolerance [J]. J Immunol, 2002, 168(5):2274-2281.

同被引文献15

引证文献1

二级引证文献1

;
使用帮助 返回顶部